KBE State Street SPDR S&P Bank ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| FLG | 1.06% |
| UBSI | 1.05% |
| ZION | 1.05% |
| FBP | 1.05% |
| APO | 1.04% |
| BBT | 1.04% |
| TFIN | 1.04% |
| BANC | 1.04% |
| WSFS | 1.04% |
| CATY | 1.04% |
ETF Analysis
Fund Overview
State Street SPDR S&P Bank ETF (KBE) currently reports 102 stock positions (subject to change), placing it in the index-like in breadth range by holdings breadth. The top line-up is FLG (1.06%), UBSI (1.05%), ZION (1.05%), with FLG as the largest single weight at 1.06%. Together, the top three holdings account for 3.16%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.
Profitability & Capital Efficiency
On the question of capital productivity, ROIC is 5.96%, WACC is 6.47%, and the economic spread is -0.51%. On balance, the spread between returns and funding costs is negative — a dynamic that pressures intrinsic value unless operating performance improves. Supporting metrics show ROE at 9.76% and ROA at 3.14%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that likely needs operating improvement before returns quality can be considered durable.
Valuation
Assessed on a multiple basis, trailing P/E of 12.55, forward P/E of 10.20, PEG of 1.26. Forward P/E tracks closely with trailing P/E — a sign that the market sees the current earnings run rate as a reasonable baseline going forward. At this PEG level, the portfolio offers what growth investors typically look for: earnings expansion priced at a reasonable relative multiple. The portfolio's holdings carry a current ratio of 3.10, pointing to strong short-term financial health. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.
Margins & Cash Generation
The margin stack reads as follows: gross margin sits at 66.77%, operating margin at 39.90%, and free cash flow margin at 35.94%. Gross margins at this level typically indicate businesses with structural pricing advantages and low direct cost sensitivity. At this level, operating margins reflect businesses with genuine scalability and above-average cost control. The portfolio's FCF margin is a standout — reflecting businesses where accounting profits translate cleanly into real cash generation. The margin profile across gross, operating, and free cash flow levels is consistently strong — a rare combination that typically indicates durable business quality.
Growth & Forward Outlook
The forward view combines two signals: the estimated 12-month price change of 15.61%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 33.41% suggesting the portfolio's businesses are collectively capturing meaningful market share or pricing power. The projected 12-month EPS growth rate of 23.1% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyThe overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.